TriangleFOR PATIENTS · SOURCE READING
Patients receive supportive care for side effects of treatment.
Source: Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 16, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview
Patients must be closely monitored during treatment of AML. Myelosuppression, a condition which results in fewer red blood cells, white blood cells, and platelets, is a side effect of both AML and treatment with chemotherapy. Supportive care during remission induction therapy may include:
Source links and citations
red blood cell and platelet transfusions to replace blood cells destroyed by the cancer or its treatment
Source links and citations
antibiotics and antifungals to prevent or treat infections
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice